JANX vs SLN: stock comparison and AI forecast
Janux Therapeutics, Inc. (JANX) and Silence Therapeutics Plc (SLN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
JANX Janux Therapeutics, Inc.
- Market Cap
- $1.11B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SLN Silence Therapeutics Plc
- Market Cap
- $1.19B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- JANX and SLN have similar market capitalizations ($1.11B and $1.19B).
- SLN carries 1.77 times debt per unit of equity, against 0.09 times for JANX.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | JANX | SLN |
|---|---|---|
| Market Cap | $1.11B | $1.19B |
| P/B Ratio | 1.20x | 30.93x |
| EPS | $-1.63 | $-0.53 |
| Book Value/Share | $15.18 | $0.64 |
| Revenue/Share | $0.33 | $0.01 |
| FCF/Share | $-0.69 | $-0.70 |
Profitability & Margins
| Metric | JANX | SLN |
|---|---|---|
| ROE | -11.1% | – |
| ROA | -10.2% | – |
| ROIC | -15.2% | -72.9% |
| Gross Margin | – | 69.8% |
| Operating Margin | -708.3% | -9023.4% |
| Net Margin | -506.2% | – |
| EBT Margin | -708.3% | -7919.6% |
| Tax Rate | – | 0.0% |
Financial Health
| Metric | JANX | SLN |
|---|---|---|
| Current Ratio | 16.35x | 7.42x |
| D/E Ratio | 0.09x | 1.77x |
| Financial Leverage | 1.09x | 2.77x |
| Working Capital | $923M | $82M |
Cash Flow
| Metric | JANX | SLN |
|---|---|---|
| Operating Cash Flow | -$41M | -$42M |
| Free Cash Flow | -$42M | -$42M |
| Capital Spending | -$670K | $0.00M |
| FCF/Sales | -206.9% | -5583.4% |
| CapEx/Sales | 3.3% | 0.4% |
Operational Efficiency
| Metric | JANX | SLN |
|---|---|---|
| Asset Turnover | 0.02x | 0.01x |
| Receivables Turnover | 136.0x | – |
| Fixed Assets Turnover | 6.2x | 0.6x |
| Days Sales Outstanding | 3 days | – |
Income Statement
| Metric | JANX | SLN |
|---|---|---|
| Total Revenue | $20M | $760K |
| Operating Income | -$144M | -$68M |
| Net Income | -$103M | – |
| R&D Expense | $124M | $48M |
| Cost of Goods Sold | – | $90K |
Dividend & Shareholder Information
| Metric | JANX | SLN |
|---|---|---|
| Shares Outstanding | 61M | 60M |
JANX vs SLN: stock comparison and AI forecast
Which is bigger, JANX or SLN?
JANX and SLN have similar market capitalizations ($1.11B and $1.19B).
Which one does Intratio's AI model rank higher, JANX or SLN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.